The MDR1 gene product, P-glycoprotein (P-gp), works as a ing its functional activity. [24] [25][26] The detection of P-gp activity transmembrane efflux pump for several cytotoxic products, in human tumor samples is of great clinical interest, parti- We have studied the functional activity of P-gp in human leuand (3) flow cytometric efflux assays with fluorescent dyes. ter to study the cellular drug resistance phenotype.
physiological conditions, and membrane permeable, which shows a rapid uptake by mitochondria in living cells. 38 It has been used in diverse studies, particularly in the investigation Introduction of drug resistance, 39 assessment of mitochondrial bioenergetics in living cells 40 (ie enzymatic activity and mitochondrial Multidrug resistance (MDR) in tumor cells is associated with transmembrane potential assessment); isolation of primitive the overexpression of mdr encoding genes, whose expression bone marrow hematopoietic progenitor cells, 41 the study of confers cellular drug resistance against some specific anticell-cycle processes, 42 and the staining of living microtumor agents.
1-4 P-glycoprotein (P-gp), the product of the mdr organisms. 43 With regard to drug resistance assessment, congene, is a M r 170 000-180 000 energy-dependent transmemditions for the action of P-gp depend on the mitochondrial brane pump [5] [6] [7] which extrudes a diverse group of unrelated membrane potential and cell membrane potential, as well as compounds, such as the Vinca alkaloids, anthracyclines, epion the time and temperature of exposure, and drug concenpodophyllotoxins, taxol, and certain protein synthesis inhibitration. Since living cells are sensitive to these changes, 44 pretors, [8] [9] [10] [11] resulting in a decreased, and less toxic, intracellular liminary studies of the transporter activity are needed in order concentration of anticancer agents. 12, 13 However, increased accurately to design and interpret future experiments. This levels of P-gp are not the only cause of MDR; other mechpaper focuses on the study of the P-gp function, as determined anisms can be involved, such as the overexpression of the with Rh123 and flow cytometry, as well as on the effect of drug resistant MRP (MDR-associated protein) gene, which has diverse efflux blockers on Rh123 retention by tumor cells. been observed in non-P-gp cell lines selected for resistance to cytotoxic drugs. cells with an optimal density of 5 × 10 5 cells/ml were prepared to the culture medium, in the presence or absence of either Vpl, CsA, or PSC-833. After 1 h of incubation, cells were for uptake and retention experiments. Cell lines were periodically tested for Mycoplasma infection and found to be negawashed and fed with Rh123-free culture medium, and cultured for 90 min at 37°C, again in the presence or absence of tive. Cell viability was determined by trypan blue exclusion using a hemocytometer.
the MDR reversing agents, to evaluate their effect on Rh123 retention. Afterwards, cells were incubated in Rh123-free medium. Life-gate was based in light scatter parameters and in simultaneous staining with 5 g/ml propidium iodide. Cellular
Clinical samples
efflux of Rh123 was measured by monitoring its fluorescence decrease at 525 nm emission wavelength. Analysis of 10 4 cells Peripheral blood and bone marrow specimens from healthy donors were collected in heparinized tubes. Mononuclear per sample was carried out in the Rh123/count four decades log histogram, collecting the autofluorescence signal in the cells were prepared by Ficoll-Hypaque density gradient centrifugation (Pharmacia, Uppsala, Sweden) according to the first decade. All analyses were performed in triplicate in three separate experiments, and the results were expressed as the manufacturer's recommendations, washed, and resuspended in phosphate-buffered saline (pH = 7.4). In all cases viability mean of fluorescence intensity. was Ͼ90% by trypan blue exclusion. 
Multicolor flow cytometric analysis Source of drugs and chemicals

Flow cytometry
Flow cytometric data were collected on an EPICS Elite ESP Rhodamine 123 uptake/retention assays cell sorter and on an EPICS XL-MCL (Coulter Electronics, Hialeah, FL, USA). All studies were carried out using an airIn order to achieve optimal growth conditions, cells were seeded 12 h before the Rh123 uptake/retention experiments cooled 15 mW argon laser (Cyonics, Hialeah, FL, USA), operating at a 488 nm wavelength. Forward scatter and side in 6-well tissue culture plates (Costar, Cambridge, MA, USA), at a final concentration of 5 × 10 5 cells/ml, in 3 ml of RPMI scatter were collected on linear scale and were used to exclude dead cells and cell aggregates either with logarithmi-1640 media (Gibco, Life Technologies, Gaithersburg, MD, USA). Rh123 uptake assays were performed by adding cally amplified Pl fluorescence (collected through a 620 nm bandpass filter) or with 7-AAD fluorescence (collected 200 ng/ml of the dye (stock solution 1 mg/ml in distilled H 2 O) through a 675 nm bandpass filter). Analyses were carried out using the Elite Workstation Software Ver. 4.01 and the WinMDI Ver 2.1.3. Software.
Results and discussion
Rh123 uptake and retention depends on both the mitochondrial and the cell membrane potential. Therefore, the integrity of the cell membrane must be assessed in Rh123 experiments by parameters other than light scatter (life-gate). Rh123 charged cells are excited with a 488 nm wavelength and analyzed through a band pass (BP) filter of 525 nm (green fluorescence). Then, simultaneous staining with propidium iodide (red fluorescence), a non-permeant dye that cannot stain living cells, is used to overcome artifactual uptake and retention phenomenon results. 18 In addition, normal and tumor cells must be characterized taking into consideration that forward scatter vs Rh123 fluorescence histograms can indicate heterogeneity of Rh123 retention, and show the effect of inhibitors or MDR indicator dyes on scatter and viability. 33 Since one of the major limiting points in Rh123 uptake and retention experiments is that dye-efflux is affected by Rh123 concentration, optimal Rh123 concentration, time, and tem- directly correlates with its intracellular concentration: from 50 g/ml up to 100 g/ml, Rh123 can be toxic to entire cells exposed over 24 h at 37°C, while using isolated mitochondria, 5 g/ml Rh123 inhibit ATP synthesis. 40 Rh123 acts inhibiting mitochondrial ATP synthesis, 45, 46 mitochondrial protein synthesis, 47 mitochondrial transhydrogenase, 48 protein kinase C, and calmodulin activities. 40, 45, 49 As shown in Figure 1 , the accumulation of Rh123 in living cells is concentration, time and temperature dependent. Leukemic cells at 4°C, 21°C and 37°C show differential Rh123 accumulation, which is higher as the temperature increases, probably as a consequence of the variation in the metabolic rate and in the mitochondrial membrane potential. Similarly, increasing the Rh123 concentration from 100 to 200 ng/ml, leads to approximately twice the fluorescence intensity. Since the fluorescence intensity depends on the Rh123 concentration, in the majority of cases, adjustment of the concentration of dye may facilitate simultaneous flow cytometric multicolor analysis.
The rapid accumulation of Rh123 by living cells can be demonstrated by a simple and rapid kinetic assay, using a histogram with time as a cytometric parameter (X-axis) vs the logarithmic green fluorescence signal (Y-axis). This assay overlapping spectra occur, as in the case of simultaneous staining with certain antibodies and fluorescent probes. Autolevels and to evaluate the changes in the fluorescence fluorescence needs to be adjusted near the first decade of the intensity. green log fluorescence and registered for 100-150 s. Then, Decreased drug accumulation in cancer cells can be acquisition is paused for approximately 10 s in order to add reversed by using modifiers of multidrug resistance. [52] [53] [54] [55] [56] [57] CerRh123 and reach the appropriate fluorochrome concentration tain P-gp competitive inhibitors, such as the calcium channel to the cell suspension. Following this, and after continuous blocker verapamil, cyclosporin A, and the cyclosporin derivafluorescence registering, sample acquisition is stopped after tive PSC-833 act by blocking the Rh123 transport. Figure 4 5-10 min, the time commonly needed for cells to reach a plateau in the presence of Rh123. Figure 2 describes a typical experiment using mobilized peripheral blood cells from patients undergoing autologous stem cell transplantation. A multicolor triple cell staining is performed to show simultaneously the kinetics of Rh123 uptake (Rh123, green fluorescence), the presence of cell progenitors (CD34 monoclonal antibody, 8G12·PE, orange fluorescence), and the assessment of cell membrane integrity. The latter parameter was achieved by means of life-gating with 7-aminoactynomicin D (far red fluorescence), an alternative DNA dye which can be used for the exclusion of non-viable cells. 51 Usually, the time needed to obtain a complete fluorescence register, or the time needed to perform Rh123 uptake and retention experiments, can surpass this 5-10 min of continuous acquisition. As shown in Figure 2d , Rh123 uptake seems to reach a plateau within 5-10 min. However, when longer time-points of Rh123 uptake are analyzed (Figure 1) , we observe that the fluorescence intensity increases with time. To overcome this discrepancy, we have used the time-interval acquisition technique. This technique involves quantitation of the changes in the fluorescence intensity for up to 3 h, depending on the drug used after the dye accumulation. First, the living cells are kept at 37°C in the presence of 200 ng/ml of Rh123 for 60 min and then analyzed to evaluate the intracellular concentration of Rh123 at 5-10 min intervals (see Figure 3) . Efflux experiments combining simultaneous antibody staining must include control samples for adequate color a blank sample is used in order to set the autofluorescence shows the in vitro effect of MDR reversing agents on Rh123 transport in leukemic cells. These experiments were performed using myeloblastic P-gp-positive KG1 and KG1a cells and erythroleukemic P-gp-negative K562 cells, either in the presence or absence of 10 g/ml verapamil, as described in the Materials and methods section. After cold washes with buffered solutions with or without the specific inhibitor, cells were re-seeded in Rh123-free medium, cultured at 37°C, and analyzed for Rh123 fluorescence at 30, 60, 120, 180 and 240 min. In KG1 and KG1a cells, the decrease in Rh123 fluoresence observed is prevented when Vpl is added, showing its capacity to reverse P-gp activity. However, K562 cells were not able to extrude Rh123 in the same conditions as myeloblastic cells. When Vpl is not present in the medium, the differences observed in the mean intensity of fluorescence, up to five-fold in K562 cells, could be due to a decreased accumulation of Rh123 in these myeloblastic cell lines.
Although it is therefore likely that the retention and distribution of cytotoxic agents might be related to the plasma membrane electrochemical potential, P-gp could also be involved in regulating the influx/efflux rate. of specific inhibitors on drug transport. Even though flow cytometric time-interval acquisition techniques achieve less precise kinetic measurements, they offer advantages for studies to calculate the 50% decrease of fluorescence, the initial 10 min time interval must be investigated. From the efflux on the heterogeneity of drug retention by clinical samples, as well as for the different effects of P-gp modulators on specific curves obtained, it can be estimated that KG1 cells need 2-3 min to achieve the 50% decrease of fluorescence, while cell populations. As shown in Figure 5 , myeloblastic KG1 and KG1a cells show very similar Rh123-efflux curves at 10 min KG1a cells need between 5 and 6 min (50%/t 50 average rate of Rh123 efflux, or time that P-gp takes for 50% of the Rh123 time intervals over a period of 60 min. Since it may be very difficult to derive an equation to fit these curves, the measureto be transported out of the cells). From these data we can show differences in the velocity of the transporter, considering ment of the initial reaction velocity should be used to calculate the first part of the curve and to draw a tangent at the that the causes contributing to the decrease in velocity with time, such as the level of saturation with Rh123, may not have origin. The curves are usually virtual straight lines, as long as the amount of change does not exceed 20% of the total. Thus, an effect within the linear phase. In order to analyse the effect of specific P-gp modulators on the Rh123 efflux, and to determine the relative concentrations at which Vpl, CsA, and PSC-833 begin to reverse Rh123 transport, cell cultures pre-loaded with Rh123 (200 ng/ml) and several concentrations of these inhibitors were tested. It has been described that MDR modulators have a decreased activity in the presence of serum due to high plasma protein binding, thus altering Rh123 experiments. 58 We have studied the modulation of P-gp in both FCS-free medium and in medium supplemented with FCS, by means of a flow cytometric functional analysis in cells overexpressing the mdr1 gene. Firstly, as shown in Figure 6 , the inhibition of Rh123 efflux was dependent on the P-gp reversing agent used, showing that the relative inhibitory efficiency for different modulators was PSC-833 Ͼ CsA Ͼ Vpl. Secondly, regarding the presence of serum in the media, we were not able to demonstrate a significantly decreased activity of MDR modulators in FCS when compared with FCS-free medium, with the exception of PSC-833, which showed decreased potential under FCS-free conditions (P = 0.05). However, this reduced effect was probably due to a decreased efficiency in the efflux metabolism because of the presence of serum, rather than to an inherent effect of the inhibitor. Thus, the bioavailability and doses of chemosensiti- for in vitro and in vivo assays. Rh123 efflux at low levels of drug resistance, and for the sep- clusive for the determination of drug-resistant phenotypes,
